Journal
JNCI Cancer Spectrum
Publication Date
1-4-2024
Volume
8
Issue
1
First Page
pkad107
Document Type
Open Access Publication
DOI
10.1093/jncics/pkad107
Rights and Permissions
Marina Elena Cazzaniga, Foluso Ademuyiwa, Thierry Petit, Joke Tio, Daniele Generali, Eva M Ciruelos, Nadia Califaretti, Brigitte Poirier, Antonio Ardizzoia, Arnd Hoenig, Benno Lex, Marie-Ange Mouret-Reynier, Dagmar Giesecke, Nicolas Isambert, Ricardo Masetti, Lacey Pitre, Denise Wrobel, Paule Augereau, Manuela Milani, Sara Rask, Christine Solbach, Laura Pritzker, Sanaa Noubir, Amadeo Parissenti, Maureen E Trudeau, Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer, JNCI Cancer Spectrum, Volume 8, Issue 1, February 2024, pkad107, https://doi.org/10.1093/jncics/pkad107. https://academic.oup.com/jncics/article/8/1/pkad107/7479697?login=true. © The Author(s) 2023. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Cazzaniga, Marina Elena; Ademuyiwa, Foluso; and et al., "Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer." JNCI Cancer Spectrum. 8, 1. pkad107 (2024).
https://digitalcommons.wustl.edu/oa_4/2957
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
